MEDP - Company ID 0001668397
The table below shows Medpace Holdings, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $2.53B | $2.11B | $1.89B | $1.46B | $1.14B | $925.92M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A | $197.56M |
Medpace Holdings, Inc. reported annual revenue of $2.53B for fiscal year 2025. That is up 20.0% from $2.11B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $421.58M (FY 2016) to $2.53B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $180.18M |
| $161.35M |
| $131.40M |
| $108.42M |
| $92.16M |
| Operating income | $534.93M | $446.87M | $336.82M | $278.70M | $198.62M | $167.04M |
| Income tax | $91.25M | $71.54M | $52.87M | $37.49M | $20.00M | $23.15M |
| Net income | $451.12M | $404.39M | $282.81M | $245.37M | $181.85M | $145.38M |
| EPS (diluted) | $15.28 | $12.63 | $8.88 | $7.28 | $4.81 | $3.84 |